You should look at the financials, or wait for the Q3 report. The day to day operation could likely be sustained for quite a while based on what they report. The bigger issue is cash to get approvals and new products to market. The legal fees are another matter and that consideration will likely be aired shortly.
They are still selling product and we'll see what the Q3 revs look like before any further judgement can be made on how long cash will last.
(2)
(1)
Decision Diagnostics Corp (DECN) Stock Research Links